Aims and objectives
BRCA mutation represents a crucial information for breast cancer personalized screening and requires MR evaluation of the breast glands in order to detect early breast cancer.
The aim of the study is to evaluate a possible correlation between imaging and histopathological characteristics and BRCA 1 or BRCA 2 genetic mutations in the breast cancer.
Methods and materials
464 patients selected between 2013 and 2017,
97patients were included (94 women,
3 males),
between probands and family members,
with BRCA 1 (52) and BRCA 2 (45) mutation,
affected by breast cancer,
undergoing mammography,
ultrasound and MRI.
MR imaging examinations were performed on a 1.5 TMR device (Achieva®,
Philips Medical Systems,
Best,
The Netherlands) by using a four channel breast coil.
MR examination was performed in the second week of menstrual cycle in case of pre-menopausal women.
The protocol included a short TI inversion recovery...
Results
Concerning the histological and receptorial pattern,
the triple negative subtype was prevalent among BRCA 1 lesions compared to the BRCA 2 related (37.5% vs.
12.5%).
At mammography,
ultrasound and MRI,
the BRCA 1 related lesions tend to present oval morphology and regular edges compared with BRCA 2 lesions (29.1% vs 8%).
At the MRI exam,
BRCA 2 related lesions presented irregular morphology and margins and inhomogeneous enhancement (88% vs.
67.3%) as compared with BRCA 1.
In BRCA 1 mutated patients the percentage of lesions with...
Conclusion
Breast BRCA 1 tumors show more regular morphological featues in the different imaging methods.
However,
among the BRCA 1 lesions,
the triple negative pattern results to be prevalent.
Personal information
Dr Simona Paolicelli
Breast Care Unit
Department of Radiology
University of Bari Medical School
Italy
[email protected]
References
1.Association of BRCA Mutation Types,
Imaging Features,
and Pathologic Findings in Patients With Breast Cancer With BRCA1 and BRCA2 Mutations.
Ha SM1,Chae EY2,Cha JH2,Kim HH2,Shin HJ2,Choi WJ2.AJR Am J Roentgenol.2017 Oct;209(4):920-928.
doi: 10.2214/AJR.16.16957.
2.Breast tumor characteristics ofBRCA1andBRCA2gene mutation carriers on MRI.Veltman J,
Mann R,
Kok T,
et al.Eur Radiol2008; 18:931–938.
3.Magnetic resonance imaging of breast cancer patients with BRCA mutation.Chung SY,
Cha JH,
Kim HH,
et al.J Korean Soc Magn Reson Med2013; 17:207–214.
4.Association betweenBRCAmutation status,
pathological findings,
and magnetic resonance imaging features in patients...